Veracyte's Lung Cancer Test Shows Promise
This article was originally published in The Gray Sheet
Executive Summary
As more people become eligible for routine annual lung cancer screenings, Veracyte says its Percepta bronchial genomic classifier lung cancer test provides a less invasive test than biopsies and more reliability than bronchoscopy alone, according to newly published data.